1651 - 1700 of 7939 Results
Title
Year
- OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBE2022OPENTitle: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBEJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.914486Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.914486/pdfCitation Count: 5
-
RESTRICTEDTitle: A Ranking-based Weakly Supervised Learning model for telemonitoring of Parkinson’s diseaseJournal Name: IISE Transactions on Healthcare Systems EngineeringPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 322End Page: 336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/24725579.2022.2091065Citation Count: 2
-
OPENTitle: Geometric framework to predict structure from function in neural networksJournal Name: Physical Review ResearchPublisher: American Physical Society (APS)Vol: 4Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1103/physrevresearch.4.023255Best OA location URL: http://link.aps.org/pdf/10.1103/PhysRevResearch.4.023255Citation Count: 7
- Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease2022OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 12
-
RESTRICTEDTitle: A late-onset neurological disorder: is progression inevitable?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105092End Page: 105092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.014Citation Count: 0
- Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism2022OPENTitle: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 39End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019Citation Count: 0
- Telemedicine as an Untapped Opportunity for Parkinson’s Nurses Training in Personalized Care Approaches2022OPENTitle: Telemedicine as an Untapped Opportunity for Parkinson’s Nurses Training in Personalized Care ApproachesJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 12Issue #: 7Start Page: 1057End Page: 1057Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm12071057Best OA location URL: https://www.mdpi.com/2075-4426/12/7/1057/pdf?version=1656473097Citation Count: 2
- Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations2022OPENTitle: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformationsJournal Name: Protein SciencePublisher: WileyVol: 31Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pro.4360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.4360Citation Count: 8
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601Citation Count: 0
- Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease2022OPENTitle: Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s diseaseJournal Name: EJNMMI ResearchPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13550-022-00910-1Best OA location URL: https://ejnmmires.springeropen.com/counter/pdf/10.1186/s13550-022-00910-1Citation Count: 7
- Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetJournal Name: Pharmacological ReportsPublisher: Springer Science and Business Media LLCVol: 74Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43440-022-00378-9Citation Count: 4
-
OPENTitle: Genetic prediction of impulse control disorders in Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 7Start Page: 936End Page: 949Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51569Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268896Citation Count: 20
- Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits2022OPENTitle: Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficitsJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 129Issue #: 8Start Page: 1001End Page: 1009Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-022-02523-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308723Citation Count: 11
-
OPENTitle: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease PathogenesisJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 13Start Page: 7086End Page: 7086Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms23137086Best OA location URL: https://www.mdpi.com/1422-0067/23/13/7086/pdf?version=1656497147Citation Count: 9
- ggtranscript: an R package for the visualization and interpretation of transcript isoforms usingggplot22022OPENTitle: ggtranscript: an R package for the visualization and interpretation of transcript isoforms usingggplot2Journal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 38Issue #: 15Start Page: 3844End Page: 3846Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/bioinformatics/btac409Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/38/15/3844/49884398/btac409.pdfCitation Count: 138
- Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment2022OPENTitle: Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive ImpairmentJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 81Issue #: 8Start Page: 643End Page: 649Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlac042Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297096Citation Count: 7
-
OPENTitle: ePostersJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: S1Start Page: 374End Page: 837Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.15466Best OA location URL: https://openaccess.sgul.ac.uk/id/eprint/114649/1/EAN%202022%20MRS-D%20abstract.docxCitation Count: 11
-
OPENTitle: Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasisJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 16Start Page: 3045End Page: 3060.e11Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2022.06.005Best OA location URL: https://doi.org/10.1016/j.molcel.2022.06.005Citation Count: 35
- Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in Mice2022OPENTitle: Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in MiceJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.886575Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.886575/pdfCitation Count: 13
- Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder2022OPENTitle: Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior DisorderJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 6Start Page: 1921End Page: 1935Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223201Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223201?id=journal-of-parkinsons-disease%2Fjpd223201Citation Count: 11
-
OPENTitle: SymposiaJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: S1Start Page: 6End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.15461Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15461Citation Count: 1
-
OPENTitle: Abnormal DaTscan in GM1‐Gangliosidosis Type III Manifesting with Dystonia‐ParkinsonismJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 825End Page: 828Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13512Citation Count: 2
-
OPENTitle: Coherent Structural and Functional Network Changes after Thalamic Lesions in Essential TremorJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1924End Page: 1929Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29130Best OA location URL: https://pub.dzne.de/record/164865/files/DZNE-2022-01309.pdfCitation Count: 6
- Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental Disabilities2022RESTRICTEDTitle: Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental DisabilitiesJournal Name: Psychiatric ServicesPublisher: American Psychiatric Association PublishingVol: 73Issue #: 12Start Page: 1389End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.ps.202100524Citation Count: 13
- Physical inactivity is associated with Parkinson's disease mild cognitive impairment and dementia2022OPENTitle: Physical inactivity is associated with Parkinson's disease mild cognitive impairment and dementiaJournal Name: Mental Health and Physical ActivityPublisher: Elsevier BVVol: 23Issue #:Start Page: 100461End Page: 100461Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mhpa.2022.100461Best OA location URL: https://doi.org/10.1016/j.mhpa.2022.100461Citation Count: 10
- Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson’s disease.2022OPENTitle: Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 6Start Page: 505End Page: 512Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1037/neu0000837Best OA location URL: https://doi.org/10.1037/neu0000837Citation Count: 5
- Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease Progression2022OPENTitle: Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease ProgressionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 909End Page: 919Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13511Best OA location URL: https://doi.org/10.1002/mdc3.13511Citation Count: 4
- Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts2022OPENTitle: Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohortsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 9Start Page: 952End Page: 959Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2021-327376Best OA location URL: https://jnnp.bmj.com/content/jnnp/93/9/952.full.pdfCitation Count: 9
- Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease2022OPENTitle: Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01388-7Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01388-7Citation Count: 54
- Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites2022RESTRICTEDTitle: Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact SitesJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.900338Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.900338/pdfCitation Count: 13
- Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms2022OPENTitle: Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive SymptomsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1644End Page: 1653Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29128Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545646Citation Count: 64
-
OPENTitle: Genome Sequencing in the Parkinson Disease ClinicJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200002Best OA location URL: https://ng.neurology.org/content/nng/8/4/e200002.full.pdfCitation Count: 11
-
OPENTitle: Measuring evolution learning: impacts of student participation incentives and test timingJournal Name: Evolution: Education and OutreachPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12052-022-00166-2Best OA location URL: https://evolution-outreach.biomedcentral.com/counter/pdf/10.1186/s12052-022-00166-2Citation Count: 2
-
OPENTitle: Multimodal deep learning for Alzheimer’s disease dementia assessmentJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31037-5Best OA location URL: https://www.nature.com/articles/s41467-022-31037-5.pdfCitation Count: 119
- Satellite repeat transcripts modulate heterochromatin condensates and safeguard chromosome stability in mouse embryonic stem cells2022OPENTitle: Satellite repeat transcripts modulate heterochromatin condensates and safeguard chromosome stability in mouse embryonic stem cellsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31198-3Best OA location URL: https://www.nature.com/articles/s41467-022-31198-3.pdfCitation Count: 30
- Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management Study2022OPENTitle: Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management StudyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 844End Page: 856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12696Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12696Citation Count: 9
- Moving the Dial Toward Equity in Parkinson’s Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial Participation2022RESTRICTEDTitle: Moving the Dial Toward Equity in Parkinson’s Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial ParticipationJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 8Start Page: 475End Page: 483Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-022-01212-8Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578442Citation Count: 12
- Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s disease2022OPENTitle: Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 10Start Page: 5510End Page: 5520Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-022-11221-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-022-11221-9.pdfCitation Count: 14
-
OPENTitle: Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1761End Page: 1767Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29124Best OA location URL: https://biblio.ugent.be/publication/8763209/file/8763211.pdfCitation Count: 5
- Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial2022OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 6
-
RESTRICTEDTitle: Racial Disparities Remain in Access to Deep Brain StimulationJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 22Issue #: 12Start Page: 1,25,26End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000840588.90259.50Citation Count: 0
- The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort2022OPENTitle: The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI CohortJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.892493Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.892493/pdfCitation Count: 12
-
OPENTitle: Racial disparities in hypertension management among multiple sclerosis patientsJournal Name: Multiple Sclerosis and Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 103972End Page: 103972Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.msard.2022.103972Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308758Citation Count: 9
- Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease2022OPENTitle: Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.009Best OA location URL: http://manuscript.elsevier.com/S1353802022001924/pdf/S1353802022001924.pdfCitation Count: 5
- Cortical and Subthalamic Nucleus Spectral Changes During Limb Movements in Parkinson's Disease Patients with and Without Dystonia2022OPENTitle: Cortical and Subthalamic Nucleus Spectral Changes During Limb Movements in Parkinson's Disease Patients with and Without DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1683End Page: 1692Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29057Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29057Citation Count: 5
- Integrating Data Directly into Publications with Augmented Reality and Web-Based Technologies – Schol-AR2022OPENTitle: Integrating Data Directly into Publications with Augmented Reality and Web-Based Technologies – Schol-ARJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-022-01426-yBest OA location URL: https://www.nature.com/articles/s41597-022-01426-y.pdfCitation Count: 5
- Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment2022OPENTitle: Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairmentJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac155Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/4/fcac155/45028282/fcac155.pdfCitation Count: 20
-
RESTRICTEDTitle: Investigational therapeutics for the treatment of progressive supranuclear palsyJournal Name: Expert Opinion on Investigational DrugsPublisher: Informa UK LimitedVol: 31Issue #: 8Start Page: 813End Page: 823Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/13543784.2022.2087179Citation Count: 1
-
RESTRICTEDTitle: Pallidal neuronal activity in multiple system atrophy type P and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 15End Page: 17Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.007Citation Count: 1
- Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's Disease2022OPENTitle: Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.880583Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.880583/pdfCitation Count: 3